We provide you with 20 years of free, institutional-grade data for ACST stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ACST. Explore the full financial landscape of ACST stock.
| Reported Date | CIK | Ticker | Type |
|---|
Acasti Pharma Inc(NASDAQ:ACST) 
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patie...
Website: http://www.acastipharma.com
Founded: 2002
Full Time Employees: 32
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ACST stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.